These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7881978)

  • 1. New trends in immunosuppression for renal transplantation.
    Halloran PF
    Curr Opin Nephrol Hypertens; 1994 Nov; 3(6):575-7. PubMed ID: 7881978
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophilin binding: a more accurate measure of cyclosporine immunosuppressive activity after renal transplantation.
    Paul K; Harding MW; Marks WH; Handschumacher RE; Lorber MI
    Transplant Proc; 1991 Feb; 23(1 Pt 2):974-5. PubMed ID: 1989349
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression. Convergence of drug action.
    Freedman RB
    Nature; 1989 Oct; 341(6244):692. PubMed ID: 2477712
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression. Binding by design.
    Ringe D
    Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo pharmacological effects of ciclosporin and some analogues.
    Borel JF; Baumann G; Chapman I; Donatsch P; Fahr A; Mueller EA; Vigouret JM
    Adv Pharmacol; 1996; 35():115-246. PubMed ID: 8920206
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.
    Kay JE
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunophilin-sensitive protein phosphatase action in cell signaling pathways.
    Schreiber SL
    Cell; 1992 Aug; 70(3):365-8. PubMed ID: 1379518
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protein folding and its catalysts in the cell].
    Takahashi N; Hayano T; Suzuki M
    Tanpakushitsu Kakusan Koso; 1991 Sep; 36(11):1821-34. PubMed ID: 1956998
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cyclolinopeptide A on T lymphocyte activation and peptidyl prolyl isomerase activity.
    Gaymes TJ; Carrett NJ; Patel N; Kay JE; Siemion IZ
    Biochem Soc Trans; 1996 Feb; 24(1):90S. PubMed ID: 8674774
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanisms of action of cyclosporin A : implications for its side effects.
    Takahashi N
    J Toxicol Sci; 1995 Sep; 20(4):480-2. PubMed ID: 8531247
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of the immunosuppressive properties of cyclosporine analogues.
    Reem GH; el Rouby S; Shi Y
    Ann N Y Acad Sci; 1993 Jun; 685():336-8. PubMed ID: 8363236
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporin G and metabolite binding to cyclophilin and a 50-kDa binding protein related to in vitro immunosuppression.
    Donnelly JG; Chen Y; Yatscoff RW; Copeland KR; Palaszynski EW; Soldin SJ
    Clin Chem; 1993 Jan; 39(1):122-5. PubMed ID: 8419033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophilins and immunosuppression by cyclosporins and macrolide structures.
    Schreier MH
    Acta Derm Venereol Suppl (Stockh); 1994; 186():100. PubMed ID: 7521103
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunophilin structure: a template for immunosuppressive drug design?
    Walkinshaw MD; Kallen J; Weber HP; Widmer A; Widmer H; Zurini M
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):8-13. PubMed ID: 1496694
    [No Abstract]   [Full Text] [Related]  

  • 18. Biosynthesis and mechanism of action of cyclosporins.
    Lawen A
    Prog Med Chem; 1996; 33():53-97. PubMed ID: 8776941
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of cyclosporine and metabolite binding to cyclophilin and a 50 kDa binding protein with in vitro immunosuppression: a preliminary report.
    Donnelly JG; Russell RL; Palaszynski EW; Copeland KR; Yatscoff RW; Chan MM; Soldin SJ
    Clin Biochem; 1991 Feb; 24(1):71-4. PubMed ID: 2060135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.
    Harding MW; Galat A; Uehling DE; Schreiber SL
    Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.